Remeditex Ventures
Venture capital · Dallas, Texas, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio1 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Prelude Therapeutics
16Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Caris Life Sciences | Medtech | Public | — | — |
Peer ranks
Portfolio size#189
Portfolio exits#160
Raises, 12 months#88
Co-investors#128
Co-investors
- Altitude Life Science VenturesVenture capital1 shared
- Bay City CapitalVenture capital1 shared
- BioAdvanceVenture capital1 shared
- Boxer CapitalVenture capital1 shared
- Deerfield Capital ManagementVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
- HealthCare Royalty PartnersVenture capital1 shared
- Lightstone VenturesVenture capital1 shared
- Perceptive AdvisorsVenture capital1 shared
Sectors
- Medtech1
- Biotech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.